Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03694756 · ClinicalTrials.gov registry record · NA

TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer

A NA study of Breast Cancer, sponsored by Montefiore Medical Center.

Recruiting
Registry status
NA
Development phase
95
Enrollment target
1
Study location

NCT03694756 is a NA study of Breast Cancer that is actively recruiting participants, run by Montefiore Medical Center. The registered enrollment target is 95 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03694756, a NA study of Breast Cancer, is actively recruiting participants, sponsored by Montefiore Medical Center.

RECRUITING
Registry status
NA
Development phase
95 participants
Enrollment target
1
Study location

Study Summary

The aim of this study is to assess feasibility of a new imaging technology in the management of breast cancer - Tumor Microenvironment of Metastasis - Magnetic Resonance imaging (TMEM-MRI).

Conditions Studied

Interventions

  • DEVICE TMEM-MRI
  • PROCEDURE FNA

Study Locations (1)

New York

  • Montefiore Medical Center - The Bronx

Trial Details

FieldValue
Enrollment Target 95 participants
Start Date 2018-12-12
Est. Completion 2026-12
Phase NA

Sponsor

Montefiore Medical Center

345 total trials

What the Registry Record Tells You About NCT03694756

The ClinicalTrials.gov registry entry for NCT03694756 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (97% lower). The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which TMEM-MRI is the first listed.

NCT03694756 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT03694756 about?

NCT03694756 is a clinical study titled "TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer". The aim of this study is to assess feasibility of a new imaging technology in the management of breast cancer - Tumor Microenvironment of Metastasis - Magnetic Resonance imaging (TMEM-MRI).

What is the current status of trial NCT03694756?

This trial is currently recruiting. It is a NA study. The enrollment target is 95 participants. The study started on 2018-12-12. Estimated completion is 2026-12.

What conditions does trial NCT03694756 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT03694756?

The interventions under investigation include: TMEM-MRI (DEVICE), FNA (PROCEDURE).

Who is sponsoring clinical trial NCT03694756?

This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03694756 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.